Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.

Liu L, Mills PJ, Rissling M, Fiorentino L, Natarajan L, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S.

Brain Behav Immun. 2012 Jul;26(5):706-13. doi: 10.1016/j.bbi.2012.02.001.

2.

The longitudinal relationship between fatigue and sleep in breast cancer patients undergoing chemotherapy.

Liu L, Rissling M, Natarajan L, Fiorentino L, Mills PJ, Dimsdale JE, Sadler GR, Parker BA, Ancoli-Israel S.

Sleep. 2012 Feb 1;35(2):237-45. doi: 10.5665/sleep.1630.

3.

Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study.

Ancoli-Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, Mills PJ, Parker BA, Sadler GR, Maglione J.

Support Care Cancer. 2014 Sep;22(9):2535-45. doi: 10.1007/s00520-014-2204-5.

4.

Pre-treatment symptom cluster in breast cancer patients is associated with worse sleep, fatigue and depression during chemotherapy.

Liu L, Fiorentino L, Natarajan L, Parker BA, Mills PJ, Sadler GR, Dimsdale JE, Rissling M, He F, Ancoli-Israel S.

Psychooncology. 2009 Feb;18(2):187-94. doi: 10.1002/pon.1412.

5.

Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.

Wang XS, Williams LA, Krishnan S, Liao Z, Liu P, Mao L, Shi Q, Mobley GM, Woodruff JF, Cleeland CS.

Brain Behav Immun. 2012 Jul;26(5):699-705. doi: 10.1016/j.bbi.2011.12.007.

6.

Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?

Bower JE, Ganz PA, Irwin MR, Kwan L, Breen EC, Cole SW.

J Clin Oncol. 2011 Sep 10;29(26):3517-22. doi: 10.1200/JCO.2011.36.1154.

7.

Effect of exercise on biomarkers, fatigue, sleep disturbances, and depressive symptoms in older women with breast cancer receiving hormonal therapy.

Payne JK, Held J, Thorpe J, Shaw H.

Oncol Nurs Forum. 2008 Jul;35(4):635-42. doi: 10.1188/08.ONF.635-642.

PMID:
18591167
8.

Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy.

Berger AM, Farr LA, Kuhn BR, Fischer P, Agrawal S.

J Pain Symptom Manage. 2007 Apr;33(4):398-409.

9.

Sleep disturbance, cytokines, and fatigue in women with ovarian cancer.

Clevenger L, Schrepf A, Christensen D, DeGeest K, Bender D, Ahmed A, Goodheart MJ, Penedo F, Lubaroff DM, Sood AK, Lutgendorf SK.

Brain Behav Immun. 2012 Oct;26(7):1037-44. doi: 10.1016/j.bbi.2012.04.003.

10.

Ecological momentary assessment of sleep, symptoms, and mood during chemotherapy for breast cancer.

Ratcliff CG, Lam CY, Arun B, Valero V, Cohen L.

Psychooncology. 2014 Nov;23(11):1220-8. doi: 10.1002/pon.3525.

11.

Fatigue and Circadian Activity Rhythms in Breast Cancer Patients Before and After Chemotherapy: A Controlled Study.

Liu L, Rissling M, Neikrug A, Fiorentino L, Natarajan L, Faierman M, Sadler GR, Dimsdale JE, Mills PJ, Parker BA, Ancoli-Israel S.

Fatigue. 2013;1(1-2):12-26.

12.

A comparison of disrupted sleep patterns in women with cancer-related fatigue and postmenopausal women without cancer.

Wu HS, Davis JE, Padiyar JP, Yarandi H.

Eur J Oncol Nurs. 2011 Sep;15(4):318-24. doi: 10.1016/j.ejon.2010.10.003.

13.

Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy.

Pusztai L, Mendoza TR, Reuben JM, Martinez MM, Willey JS, Lara J, Syed A, Fritsche HA, Bruera E, Booser D, Valero V, Arun B, Ibrahim N, Rivera E, Royce M, Cleeland CS, Hortobagyi GN.

Cytokine. 2004 Feb 7;25(3):94-102.

PMID:
14698135
14.

Relationship between fatigue, sleep quality and inflammatory cytokines during external beam radiation therapy for prostate cancer: A prospective study.

Holliday EB, Dieckmann NF, McDonald TL, Hung AY, Thomas CR Jr, Wood LJ.

Radiother Oncol. 2016 Jan;118(1):105-11. doi: 10.1016/j.radonc.2015.12.015.

PMID:
26743832
15.

Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy.

Jeste N, Liu L, Rissling M, Trofimenko V, Natarajan L, Parker BA, Ancoli-Israel S.

Qual Life Res. 2013 Aug;22(6):1239-44. doi: 10.1007/s11136-012-0243-2.

16.

Inflammatory Biomarkers, Comorbidity, and Neurocognition in Women With Newly Diagnosed Breast Cancer.

Patel SK, Wong AL, Wong FL, Breen EC, Hurria A, Smith M, Kinjo C, Paz IB, Kruper L, Somlo G, Mortimer JE, Palomares MR, Irwin MR, Bhatia S.

J Natl Cancer Inst. 2015 Jun 22;107(8). pii: djv131. doi: 10.1093/jnci/djv131.

17.

Sleep restoration is associated with reduced plasma C-reactive protein and depression symptoms in military personnel with sleep disturbance after deployment.

Heinzelmann M, Lee H, Rak H, Livingston W, Barr T, Baxter T, Scattergood-Keepper L, Mysliwiec V, Gill J.

Sleep Med. 2014 Dec;15(12):1565-70. doi: 10.1016/j.sleep.2014.08.004.

PMID:
25311836
18.

Levels of circulating interleukin-1 receptor antagonist and C-reactive protein in long-term survivors of testicular cancer with chronic cancer-related fatigue.

Orre IJ, Murison R, Dahl AA, Ueland T, Aukrust P, Fosså SD.

Brain Behav Immun. 2009 Aug;23(6):868-74. doi: 10.1016/j.bbi.2009.04.003.

PMID:
19362138
19.

Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer.

Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, Lawton S, Desan P, Liu L.

Support Care Cancer. 2012 Jun;20(6):1211-9. doi: 10.1007/s00520-011-1203-z.

20.

Relationship of menopausal status and climacteric symptoms to sleep in women undergoing chemotherapy.

Rissling MB, Liu L, Natarajan L, He F, Ancoli-Israel S.

Support Care Cancer. 2011 Aug;19(8):1107-15. doi: 10.1007/s00520-010-0914-x.

Items per page

Supplemental Content

Support Center